DEVRI CASHE: Open Payments
NPI 1912303744 · READING, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,091 in 56 payments from 8 companies in 2025. Trend: 2023 $1,987 · 2024 $1,529 · 2025 $1,091
Food & beverage: $1,091
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 27 | $482 |
| Gilead Sciences, Inc. | 15 | $261 |
| Braeburn Inc. | 2 | $98 |
| AstraZeneca Pharmaceuticals LP | 5 | $91 |
| Theratechnologies Inc. | 3 | $65 |
| Lilly USA, LLC | 2 | $44 |
| Merck Sharp & Dohme LLC | 1 | $25 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
Products named: DOVATO, RUKOBIA, BRIXADI, EGRIFTA, AIRSUPRA, FARXIGA, CABENUVA, PIFELTRO.
Industry payments across PA — which companies pay providers there.
